New cancer clinical trial: Potential of Circulating Tumor DNA to Assess the Tumor Response to Neoadjuvant Chemotherapy in Breast Cancer Patients

Published on: September 27, 2018 at 12:00PM
Conditions:   Breast Cancer;   Neoadjuvant Chemotherapy;   Circulating Tumor DNA
Intervention:  
Sponsor:   Zhiyong Yu
Not yet recruiting
https://ift.tt/2xUOcpW